* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Advanced Medical Solutions Group's PEG Ratio or its related term are showing as below:
LSE:AMS'
s PEG Ratio Range Over the Past 10 Years
Min: 0.55 Med: 1.89 Max: 138.27
Current: 9.85
During the past 13 years, Advanced Medical Solutions Group's highest PEG Ratio was 138.27. The lowest was 0.55. And the median was 1.89.
LSE:AMS's PEG Ratio is ranked worse than 91.43% of 245
companies
in the Medical Devices & Instruments industry
Industry Median: 1.98
vs LSE:AMS: 9.85
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Advanced Medical Solutions Group PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Advanced Medical Solutions Group's PEG Ratio
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group's PEG Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's PEG Ratio falls into.
Advanced Medical Solutions Group PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Advanced Medical Solutions Group (LSE:AMS) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Advanced Medical Solutions Group PEG Ratio Related Terms
Thank you for viewing the detailed overview of Advanced Medical Solutions Group's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Advanced Medical Solutions Group (LSE:AMS) Business Description
U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.
Advanced Medical Solutions Group (LSE:AMS) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:AMS has been successfully added to your 